Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3529)
All Articles published online
|
Oct 14, 2012 (publication date) through Nov 27, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Herreros-Villanueva M, Zubia-Olascoaga A, Bujanda L. c-Met in pancreatic cancer stem cells: Therapeutic implications. World J Gastroenterol 2012; 18(38): 5321-5323 [PMID: 23082047 DOI: 10.3748/wjg.v18.i38.5321] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v18/i38/5321.htm |
| Number | Citing Articles |
| 1 |
Minwei Zhou, Yantian Fang, Jianbin Xiang, Zongyou Chen. Therapeutics Progression in Pancreatic Cancer and Cancer Stem Cells. Journal of Cancer Therapy 2015; 6(03): 237 doi: 10.4236/jct.2015.63026
|
| 2 |
Marco Schiavone, Elena Rampazzo, Alessandro Casari, Giusy Battilana, Luca Persano, Enrico Moro, Shu Liu, Steven D. Leach, Natascia Tiso, Francesco Argenton. Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer. Disease Models & Mechanisms 2014; doi: 10.1242/dmm.014969
|
| 3 |
Cristiana Pistol Tanase, Ana Iulia Neagu, Laura Georgiana Necula, Cristina Mambet, Ana-Maria Enciu, Bogdan Calenic, Maria Linda Cruceru, Radu Albulescu. Cancer stem cells: Involvement in pancreatic cancer pathogenesis and perspectives on cancer therapeutics. World Journal of Gastroenterology 2014; 20(31): 10790-10801 doi: 10.3748/wjg.v20.i31.10790
|
| 4 |
Hong Hua Yan, Kyung Hee Jung, Mi Kwon Son, Zhenghuan Fang, Soo Jung Kim, Ye-Lim Ryu, Juyoung Kim, Mi-Hyun Kim, Soon-Sun Hong. Crizotinib Exhibits Antitumor Activity by Targeting ALK Signaling not c-MET in Pancreatic Cancer. Oncotarget 2014; 5(19): 9150 doi: 10.18632/oncotarget.2363
|
| 5 |
Juehua Yu, Shi-he Liu, Robbi Sanchez, John Nemunaitis, Enrique Rozengurt, F. Charles Brunicardi. Pancreatic cancer actionable genes in precision medicine and personalized surgery. The Surgeon 2017; 15(1): 24 doi: 10.1016/j.surge.2016.05.002
|
| 6 |
Cynthia I Tchio Mantho, Adriana Harbuzariu, Ruben R Gonzalez-Perez. Histone deacetylases, microRNA and leptin crosstalk in pancreatic cancer. World Journal of Clinical Oncology 2017; 8(3): 178-189 doi: 10.5306/wjco.v8.i3.178
|
| 7 |
Rekha Khandia, Bramhadev Pattnaik, Katherukamem Rajukumar, Atul Pateriya, Sandeep Bhatia, Harshad Murugkar, Anil Prakash, Hare Krishna Pradhan, Kuldeep Dhama, Ashok Munjal, Sunil K. Joshi. Anti-proliferative role of recombinant lethal toxin of Bacillus anthracis on primary mammary ductal carcinoma cells revealing its therapeutic potential. Oncotarget 2017; 8(22): 35835 doi: 10.18632/oncotarget.16214
|
| 8 |
Rio S. Boothello, Nirmita J. Patel, Chetna Sharon, Elsamani I. Abdelfadiel, Shravan Morla, Donald F. Brophy, H. Robert Lippman, Umesh R. Desai, Bhaumik B. Patel. A Unique Nonsaccharide Mimetic of Heparin Hexasaccharide Inhibits Colon Cancer Stem Cells via p38 MAP Kinase Activation. Molecular Cancer Therapeutics 2019; 18(1): 51 doi: 10.1158/1535-7163.MCT-18-0104
|
| 9 |
Arkadeep Sinha, David Cherba, Heather Bartlam, Elizabeth Lenkiewicz, Lisa Evers, Michael T. Barrett, Brian B. Haab. Mesenchymal‐like pancreatic cancer cells harbor specific genomic alterations more frequently than their epithelial‐like counterparts. Molecular Oncology 2014; 8(7): 1253 doi: 10.1016/j.molonc.2014.04.007
|
| 10 |
Giulia M. Stella, Alessandra Gentile, Alice Balderacchi, Federica Meloni, Melissa Milan, Silvia Benvenuti. Ockham’s razor for the MET-driven invasive growth linking idiopathic pulmonary fibrosis and cancer. Journal of Translational Medicine 2016; 14(1) doi: 10.1186/s12967-016-1008-4
|
| 11 |
Han-xiang Zhan, Jian-wei Xu, Dong Wu, Tai-ping Zhang, San-yuan Hu. Pancreatic cancer stem cells: New insight into a stubborn disease. Cancer Letters 2015; 357(2): 429 doi: 10.1016/j.canlet.2014.12.004
|
| 12 |
Sabrina Bimonte, Antonio Barbieri, Maddalena Leongito, Giuseppe Palma, Vitale del Vecchio, Michela Falco, Raffaele Palaia, Vittorio Albino, Mauro Piccirillo, Alfonso Amore, Antonella Petrillo, Vincenza Granata, Francesco Izzo, Hu Li. The Role of miRNAs in the Regulation of Pancreatic Cancer Stem Cells. Stem Cells International 2016; 2016(1) doi: 10.1155/2016/8352684
|
| 13 |
E. Giovannetti, C.L. van der Borden, A.E. Frampton, A. Ali, O. Firuzi, G.J. Peters. Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer. Seminars in Cancer Biology 2017; 44: 43 doi: 10.1016/j.semcancer.2017.04.006
|
| 14 |
Kozo Noguchi, Masamitsu Konno, Hidetoshi Eguchi, Koichi Kawamoto, Ryouta Mukai, Naohiro Nishida, Jun Koseki, Hiroshi Wada, Hirofumi Akita, Taroh Satoh, Shigeru Marubashi, Hiroaki Nagano, Yuichiro Doki, Masaki Mori, Hideshi Ishii. c‑Met affects gemcitabine resistance during carcinogenesis in a mouse model of pancreatic cancer. Oncology Letters 2018; doi: 10.3892/ol.2018.8793
|
| 15 |
Jassim M. Al-Hassan, Daoyan Wei, Sharmistha Chakraborty, Tara Conway, Patrea Rhea, Bo Wei, Megan Tran, Mihai Gagea, Mohammad Afzal, Sosamma Oommen, Divya Nair, Bincy M. Paul, Peiying Yang. Fraction B From Catfish Epidermal Secretions Kills Pancreatic Cancer Cells, Inhibits CD44 Expression and Stemness, and Alters Cancer Cell Metabolism. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.659590
|
| 16 |
Current World Literature. Current Opinion in Oncology 2013; 25(3): 325 doi: 10.1097/CCO.0b013e328360f591
|
| 17 |
Katherine Chang, Anand Karnad, Shujie Zhao, James W. Freeman. Roles of c-Met and RON kinases in tumor progression and their potential as therapeutic targets. Oncotarget 2015; 6(6): 3507 doi: 10.18632/oncotarget.3420
|
| 18 |
Lu Liu, Qiaoming Zhi, Meng Shen, Fei-Ran Gong, Binhua P. Zhou, Lian Lian, Bairong Shen, Kai Chen, Weiming Duan, Meng-Yao Wu, Min Tao, Wei Li. FH535, a β-catenin pathway inhibitor, represses pancreatic cancer xenograft growth and angiogenesis. Oncotarget 2016; 7(30): 47145 doi: 10.18632/oncotarget.9975
|
| 19 |
Vineet Kumar Gupta, Nikita S. Sharma, Kousik Kesh, Patricia Dauer, Alice Nomura, Bhuwan Giri, Vikas Dudeja, Santanu Banerjee, Sanjoy Bhattacharya, Ashok Saluja, Sulagna Banerjee. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. Cancer Letters 2018; 439: 101 doi: 10.1016/j.canlet.2018.09.028
|
| 20 |
In-Gyu Kim, Jae-Ha Lee, Seo-Yoen Kim, Jeong-Yul Kim, Eun-Wie Cho. Fibulin-3 negatively regulates ALDH1 via c-MET suppression and increases γ-radiation-induced sensitivity in some pancreatic cancer cell lines. Biochemical and Biophysical Research Communications 2014; 454(3): 369 doi: 10.1016/j.bbrc.2014.10.084
|
| 21 |
L. Saikrishna, Prameswari Kasa, Saimila Momin, L. V. K. S. Bhaskar. Exploring Pancreatic Metabolism and Malignancy. 2019; : 157 doi: 10.1007/978-981-32-9393-9_9
|
| 22 |
Mark Noble, Margot Mayer-Pröschel, Zaibo Li, Tiefei Dong, Wanchang Cui, Christoph Pröschel, Ibro Ambeskovic, Joerg Dietrich, Ruolan Han, Yin Miranda Yang, Christopher Folts, Jennifer Stripay, Hsing-Yu Chen, Brett M. Stevens. Redox biology in normal cells and cancer: Restoring function of the redox/Fyn/c-Cbl pathway in cancer cells offers new approaches to cancer treatment. Free Radical Biology and Medicine 2015; 79: 300 doi: 10.1016/j.freeradbiomed.2014.10.860
|
| 23 |
Nabendu Pore, Sanjoo Jalla, Zheng Liu, Brandon Higgs, Claudio Sorio, Aldo Scarpa, Robert Hollingsworth, David A. Tice, Emil Michelotti. In Vivo Loss of Function Screening Reveals Carbonic Anhydrase IX as a Key Modulator of Tumor Initiating Potential in Primary Pancreatic Tumors. Neoplasia 2015; 17(6): 473 doi: 10.1016/j.neo.2015.05.001
|
| 24 |
Howard C. Crawford, Marina Pasca di Magliano, Sulagna Banerjee. Signaling Networks That Control Cellular Plasticity in Pancreatic Tumorigenesis, Progression, and Metastasis. Gastroenterology 2019; 156(7): 2073 doi: 10.1053/j.gastro.2018.12.042
|
| 25 |
WEN-JIE WANG, MENG-YAO WU, MENG SHEN, QIAOMING ZHI, ZE-YI LIU, FEI-RAN GONG, MIN TAO, WEI LI. Cantharidin and norcantharidin impair stemness of pancreatic cancer cells by repressing the β-catenin pathway and strengthen the cytotoxicity of gemcitabine and erlotinib. International Journal of Oncology 2015; 47(5): 1912 doi: 10.3892/ijo.2015.3156
|
| 26 |
He Xu, Di Wu, Mingming Xiao, Yubin Lei, Yalan Lei, Xianjun Yu, Si Shi. PP2A complex disruptor SET prompts widespread hypertranscription of growth-essential genes in the pancreatic cancer cells. Science Advances 2024; 10(4) doi: 10.1126/sciadv.adk6633
|
| 27 |
Nirmita J. Patel, Chetna Sharon, Somesh Baranwal, Rio S. Boothello, Umesh R. Desai, Bhaumik B. Patel. Heparan sulfate hexasaccharide selectively inhibits cancer stem cells self-renewal by activating p38 MAP kinase. Oncotarget 2016; 7(51): 84608 doi: 10.18632/oncotarget.12358
|
| 28 |
Susmita Barman, Iram Fatima, Amar B. Singh, Punita Dhawan. Pancreatic Cancer and Therapy: Role and Regulation of Cancer Stem Cells. International Journal of Molecular Sciences 2021; 22(9): 4765 doi: 10.3390/ijms22094765
|
| 29 |
Divya Singh, Ghanshyam Upadhyay, Rakesh K. Srivastava, Sharmila Shankar. Recent advances in pancreatic cancer: biology, treatment, and prevention. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2015; 1856(1): 13 doi: 10.1016/j.bbcan.2015.04.003
|
| 30 |
Jorge Alberto Guadarrama-Orozco, Erika Ruiz-Garcia, Juan Carlos Casarez-Price, Samuel Rivera-Rivera, Horacio Astudillo-de la Vega. Stem Cells in Cancer: Should We Believe or Not?. 2014; : 167 doi: 10.1007/978-94-017-8754-3_8
|